NCT00080405View on ClinicalTrials.gov

Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

June 30, 2005

Conditions
Multiple Myeloma
Interventions
DRUG

Bortezomib

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY